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Abstract
Visceral adiposity is associated with cardiovascular disease, an association that may be
mediated in part by inflammation. We hypothesized that regional measures of visceral adi-
posity would associate with commonly obtained clinical measures of immune status. We
consecutively studied 3,291 subjects (mean age, 49.8±9.8 years) who underwent an annual
cardiovascular risk survey. Peri-cardial (PCF) and thoracic peri-aortic adipose tissue (TAT)
volumes were determined by dedicated computed tomography (CT) software (Aquarius 3D
Workstation, TeraRecon, San Mateo, CA, USA). Hepatic steatosis was assessed by
abdominal ultrasonography. We explored cross-sectional associations between visceral fat
measures and high-sensitivity C-reactive protein (hs-CRP), leukocyte counts, and the neu-
trophil-to-lymphocyte ration (NLR). Among 3,291 study participants, we observed positive
linear associations between PCF and TAT, higher degree of hepatic steatosis and hs-CRP,
various leukocyte counts, either total and its differential counts, and NLR (all trend p<0.001).
Multi-variate linear and logistic regression models showed independent associations
between PCF/TAT (ß-Coef: 0.14/0.16, both p<0.05) and total WBC counts, with only TAT
further demonstrated significant relations with neutrophil counts and NLR (both p<0.05) and
independently identified abnormally high WBC and NLR (Odds ratio: 1.18 & 1.21, both
p<0.05). C-statistics showed significant incremental model prediction for abnormally high
WBC and NLR (both ΔAUROC<0.05) when TAT was superimposed on traditional cardio-
vascular risks and biochemical information. Greater visceral adiposity burden and hepatic
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steatosis may be associated with higher circulating leukocyte counts and markers for ath-
erosclerosis, with more pronounced influences for peri-aortic adiposity. Our data suggested
the differential biological impacts for region-specific visceral adiposity.
Introduction
Excessive adipose tissue is associated with a chronic inflammatory status that leads to a variety
of metabolic disorders including dyslipidemia, hypertension, and type 2 diabetes with region-
specific properties [1]. Compared to subcutaneous adipose tissue, visceral adipose tissue is
functionally more active in several metabolic derangements and may not be accurately identi-
fied by traditional anthropometrics including body weight and body mass index (BMI) assess-
ment [2]. Over-production of various pro-inflammatory paracrines and mediators by visceral
adipose tissue leads to obesity-related systemic inflammation and insulin resistance [3, 4]. On
the other hand, fatty liver disease—characterized by excessive fatty infiltration of liver tissue—
is an increasingly recognized cause of chronic liver disease worldwide, and is highly associated
with central obesity, local hepatic inflammation, insulin resistance and increased systemic oxi-
dative stress [5, 6].
Typically, the local inflammatory milieu of visceral adipose tissue is characterized by mono-
cyte/macrophage infiltration and a diversity of lymphocyte subtypes [7, 8]. Additionally,
increasing evidence suggests that various adipokines, free radicals from exaggerated oxidative
stress and proinflammatory cytokines secreted directly from adipocytes may have remote
adverse cardiovascular effects in obesity [9]. Although cytokines are rarely measured in daily
practice, the total white blood cell count (WBC) and its subtypes (e.g. monocytes, lymphocytes,
neutrophils, eosinophils, and basophils) may reflect a patient‘s inflammatory status in the
absence of infection [10]. In particular, the neutrophil-to-lymphocyte ratio (NLR) has been
proposed as a risk marker for adverse inflammatory status in metabolic syndrome, several car-
diovascular disorders and cancer [11].
Recently, two volume-based measures of visceral adiposity burden—peri-cardial (PCF) and
thoracic peri-aortic adipose tissue (TAT)—have been shown to correlate with metabolic risk
profiles and atherosclerosis [12]. Studies over the past decade also suggest that both PCF and
TAT are independently associated with systemic inflammatory markers such as hs-CRP. As
region-specific visceral adiposity may have biologically diverse effects and associate with differ-
ent pathological conditions [13, 14], the aim of this study was to investigate to what extent
these visceral fat measures (including PCF, TAT and hepatic steatosis) may be associated with
circulating leukocyte counts and the NLR in a large cohort of adults in Taiwan.
Methods
Study population
From 2005 to 2009, we studied consecutive subjects who underwent a comprehensive cardio-
vascular health survey at our center that included a non-contrast computed tomography (CT)
scan of the chest to assess the presence and burden of coronary calcium. Subjects with CT data
available comprised the main study population in our current work. This study complies with
the Declaration of Helsinki, and the study protocol was approved by the Institutional Review
Board at Mackay Memorial Hospital, Taipei, Taiwan. Data were analyzed anonymously.
Ectopic visceral fat and NLR
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Abbreviations: PCF, Pericardial adipose tissue;
TAT, thoracic peri-aortic adipose tissue; VAT,
visceral adipose tissue; MDCT, multi-detector
computed tomography; hs-CRP, high-sensitive C-
reactive protein; BMI, body mass index; BSA, body
surface area; DBP, diastolic blood pressure; SBP,
systolic blood pressure; eGFR, estimated
glomerular filtration rate; HbA1c, glycosylated
hemoglobin level; HDL, high-density lipoprotein;
LDL, low-density lipoprotein.
Baseline demographics and medical history were obtained along with a detailed physical
exam. Structured questionnaires were used to quantify self-reported alcohol consumption,
smoking and physical activity. Presence of coronary arterial disease (CAD) was defined as a
history of myocardial infarction or prior history of coronary revascularization. History of
hypertension was defined as either systolic blood pressure higher than 140mmHg, diastolic
pressure higher than 90mmHg or previous diagnosed hypertension on treatment. Diabetes
was defined as current usage of any medications for diabetes or known diagnosis of diabetes.
Hyperlipidemia was defined as known history of hyperlipidemia or medications (e.g. statin or
fibrate). Anthropometric measures including height, weight, waist and hip circumferences
were all obtained. Resting blood pressures were measured by medical staff using a standardized
automated sphygmomanometer.
Biochemical data, white blood cell counts and serum markers of systemic
inflammation
Venous blood sampling and analysis were performed according to the Clinical Laboratory
Standards Institute guidelines (Specimen Choice, Collection, and Handling; Approved Guide-
line H18-A3). Levels of total white blood cell (WBC) counts (leukocytes), neutrophils, lympho-
cytes, and monocytes were all determined by an automated blood cell counter utilizing
Coulter LH780 Hematology Analyzer (Beckman Coulter Ireland Inc Mervue, Galway, Ire-
land). In our current work, absolute cell counts were used in the analyses. To ensure accuracy,
results were verified by repeating the tests on the same tube one day later. A Hitachi 7170
Automatic Analyzer (Hitachi Corp. Hitachinaka Ibaraki, Japan) was used to measure fasting
glucose, post-prandial glucose, HbA1c, uric acid, blood urea nitrogen, creatinine, homocyste-
ine, and several lipid profiles including HDL, LDL, total cholesterol and triglyceride, with esti-
mated glomerular filtration rate (eGFR) calculated using the Modification of Diet in Renal
Disease equation. High-sensitivity CRP (hs-CRP) levels were determined using a highly sensi-
tive, latex particle-enhanced immunoassay Elecsys 2010 (Roche, Mannheim, Germany).
Measurements of ectopic visceral adipose tissue
Scans were performed using a 16-slice multidetector CT (MDCT) scanner (Sensation 16; Sie-
mens Medical Solutions, Forchheim, Germany) with 16 × 0.75 mm collimation, rotation time
of 420 msec, and tube voltage of 120 kV. In one breath hold, images were acquired from above
the level of tracheal bifurcation to below the base of heart using prospective electrocar-
diographic triggering, with the center of the acquisition at 70% of the R-R interval. From the
raw data, the images were reconstructed with standard kernel in 3 mm thick axial, non-over-
lapping slices and 25 cm field of view.
PCF volumes were quantified from the heart CT scan using a dedicated workstation
(Aquarius 3D Workstation, TeraRecon, San Mateo, CA, USA). The semi-automatic segmenta-
tion technique was developed for quantification of adipose tissue volumes. We traced pericar-
dium in axial MDCT images manually from the level of left main coronary artery to
diaphragm every four to six slices. The computer software then automatically interpolated and
traced pericardium along the manually traced areas. All automatically traced slices were veri-
fied and modified if necessary for accuracy. Adipose tissue was defined as pixels within a win-
dow of -195 to -45 HU and a window center of -120 HU. Pericardial fat (PCF) was defined as
any adipose tissue located within the pericardial sac. Thoracic peri-aortic adipose tissue (TAT)
was defined as all of the adipose tissue surrounding the thoracic aorta extending 67.5 mm cau-
dally from the level of the bifurcation of pulmonary arteries. (Fig 1) This approach has previ-
ously been validated [15, 16]. Two observers performed independent readings on a random
Ectopic visceral fat and NLR
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subset of 40 subjects. The intra-observer and inter-observer coefficient of variation were
4.27%, 4.87% and 6.58%, 6.81% for PCF and TAT, respectively [15].
Ultrasonographic assessment on grade of hepatic steatosis
Hepatic ultrasonography was performed in all patients by experienced gastroenterologists,
who were blinded to the patients’ clinical data. Hepatic steatosis was diagnosed based on char-
acteristic ultrasonographic characteristics, including diffuse hyper echogenicity of the liver rel-
ative to the kidneys, ultrasonography beam attenuation, and poor visualization of the
intrahepatic vessel borders and diaphragm [17]. Ultrasonography allows detection of the pres-
ence of mild and moderate-to-severe hepatic steatosis as alternative surrogate of intra-abdomi-
nal adiposity, with a sensitivity and specificity of approximately 85% and 95%, respectively
(when liver fat infiltration on histology is at least 20–30%)[17]. We categorized hepatic steato-
sis severity (none, mild, moderate, severe) based on the intensity of hepatic hyper echogenicity
compared to the kidney.
Statistical analysis
Baseline demographics were compared across quintiles of PCF and TAT volumes, and the
Wilcoxon rank-sum test was used to estimate the statistical significance of trends across all
ordered groups. The prevalence of hepatic steatosis according to PCF/TAT quintiles was visu-
alized using bar graphs, and compared across categories using (chi-squared tests). The associa-
tions between leukocyte counts and PCF/TAT were explored using Pearson’s correlation, and
logistic regression was used to examine the association of leukocyte counts with moderate or
severe hepatic steatosis. We further conducted uni- and multi-variate linear regression models
Fig 1. Examples of PCF (A, B) and TAT (C, D) in 2D and 3D computed tomography views. A 69-year-old male with large amounts of PCF
(235.8ml), TAT (24.9ml) and the lab data (WBC: 10700/mm3, Neutrophil: 9502/mm3, NLR: 15.05, monocyte: 481/mm3) (First row). A 45-year-old
female with small amounts of PCF (18.7ml), TAT (1.24ml) and the lab data (WBC: 3900/mm3, Neutrophil: 2211/mm3, NLR: 1.702, monocyte: 238/
mm3) (Second row). PCF: peri-cardial adipose tissue; TAT: thoracic peri-aortic adipose tissue; WBC: white blood cell count; NLR: neutrophil-to-
lymphocyte ratio.
https://doi.org/10.1371/journal.pone.0207284.g001
Ectopic visceral fat and NLR
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to explore the independent relationships of ectopic fat measures (PCF/TAT and hepatic steato-
sis as independent variables) with leukocyte counts (as dependent variables) after accounting
for several key baseline clinical co-variates. Receiver operating characteristic curves with c-sta-
tistics were used to test the diagnostic performance of PCF/TAT and hepatic steatosis added to
age, gender, BMI, biochemical profiles, lifestyle factors, and medical history to identify abnor-
mally high total WBC counts (>6.9 × 103/μL)[18], and NLR (>2.51)[19]. The potential con-
founding factors for multi-variate (MV) regression models included age, gender, BMI, blood
pressure, fasting glucose, lipid profiles, renal function, medical histories of hypertension, dia-
betes, hyperlipidemia, coronary disease, smoking, and alcohol use.
All data were analyzed using STATA 12.0 (STATA Corp., College Station, Texas). All statis-
tical tests were two-sided with p<0.05 considered to be statistically significant.
Results
Baseline characteristics and circulating individual white blood cell counts
of study participants
A total of 3,291 subjects met our entry criteria and were enrolled in this study. The mean age
was 49.8 ± 9.8 years, with averaged BMI estimated to be 24.7 ± 3.5kg/m2 in our current cohort.
Baseline demographic data across quintiles of PCF and TAT are displayed in Table 1, with
mean (± standard deviation) PCF and TAT volumes of 75.7 (±30.9) and 7.1 (±4.0) ml, respec-
tively. Among 3,196 subjects with liver coding data available, 2,736 (85.6%) had no or mild
hepatic steatosis, 277 (8.7%) had moderate and 183 (5.7%) had severe hepatic steatosis.
Higher quintile of PCF and TAT volume was associated with more advanced age, higher
systolic/diastolic blood pressures, increased body height and weight, greater BMI, higher fast-
ing glucose, higher HbA1c, and unfavorable lipid profiles including higher total cholesterol,
higher low-density lipoprotein (LDL), lower level of high-density lipoprotein (HDL), and
lower estimated glomerular filtration rate (eGFR). Subjects with higher visceral fat depots were
more likely to have prevalent hypertension, diabetes, hyperlipidemia and cardiovascular dis-
ease (all p<0.05).
The association between visceral adipose tissue volume, hepatic steatosis
and circulating differential white blood cell counts
Higher hs-CRP, total WBC and higher proportions of neutrophils, eosinophils, monocytes,
lymphocytes, and myelocytes were observed with increasing amounts of PCF and TAT and
with higher grades of liver steatosis (Table 2, all p<0.01).
Volumes of PCF/TAT and hepatic steatosis severity were positively correlated with hs-CRP,
total WBC counts, and higher levels of neutrophils, eosinophils, monocytes, and lymphocytes
(Table 3). In addition, subjects with higher quintile of PCF and TAT volume were associated
with higher prevalence of hepatic steatosis (Fig 2). Volumes of PCF/TAT correlated with hs-
CRP (r = 0.18, 0.21 for PCF/TAT, both p<0.001). A graded increase of hs-CRP was also
observed across hepatic steatosis categories (0.17, 0.19 & 0.25, trend p<0.001). Further, hs-
CRP was positively associated with total WBC count (r = 0.24) and several individual white
blood cell components (r = 0.27, 0.16, 0.24 for neutrophils, monocytes, and NLR, respectively,
all p<0.001). Higher PCF and TAT along with substantially higher total WBC counts were
observed across hepatic steatosis categories (Fig 3). In multi-variate models, adjustment for
age, gender (Model 1), total body mass index (BMI, Model 2) and other clinical covariates
attenuated the relationships between visceral adiposity (PCF/TAT), hepatic steatosis and hs-
CRP, WBC or its differential blood cell types, especially for PCF and hepatic steatosis
Ectopic visceral fat and NLR
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Table 1. Baseline characteristics of the study population by PCF and TAT quintiles.
































































































































































































































































































































































































13(1.98%) 30(4.56%) 27(4.1%) 38(5.78%) 56(8.51%) <0.001 12(1.82%) 23(3.5%) 44(6.7%) 34(5.15%) 51(7.77%) <0.001
History of CAD, % 12(1.82%) 19(2.89%) 23(3.49%) 36(5.47%) 52(7.9%) <0.001 11(1.67%) 28(4.26%) 29(4.41%) 26(3.94%) 48(7.32%) <0.001
Alcohol use, % 29(4.41%) 29(4.41%) 37(5.61%) 45(6.84%) 46(6.99%) 0.1 22(3.33%) 25(3.8%) 36(5.48%) 44(6.67%) 59(8.99%) <0.001













BMI: body mass index; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; Hb: hemoglobin; HDL: high-density lipoprotein; LDL: low-density
lipoprotein; SBP: systolic blood pressure; sGPT: serum glutamate-pyruvate transaminase.
https://doi.org/10.1371/journal.pone.0207284.t001
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(Table 4). By defining abnormal total WBC count and NLR at a cut-off of 5,900 x 103μL and
2.51, respectively, higher PCF and TAT burden were significantly associated with higher risk
of abnormally high WBC count (Crude OR: 1.25 [95% CI: 1.1.15–1.35] & 1.38 [95% CI: 1.28–
1.49] for PCF & TAT, both p<0.001) and showed modest associations with abnormally high
NLR (Crude OR: 1.08 [95% CI: 0.98–1.18] & 1.12 [95% CI: 1.02–1.23], p = 0.126 & 0.014),
respectively. In fully adjusted models, only higher TAT was independently associated with
abnormally high total WBC count and NLR (adj. OR: 1.18 [95% CI: 1.05–1.33] & 1.21 [95%
CI: 1.05–1.39], p = 0.006 & 0.007 for total WBC and NLR, respectively) (Fig 4A and 4B). Exis-
tence of moderate/severe hepatic steatosis (vs. no or mild) was also associated with abnormally
high total WBC count (Crude OR: 1.42 [95% CI: 1.24.15–1.64, P<0.001]) but not abnormal
NLR (Crude OR: 1.00 [95% CI: 0.83.15–1.20, P = 0.98); however, the association between
hepatic steatosis and high WBC count was attenuated in fully adjusted models (adj. OR: 1.08,
p = 0.34) (Fig 4A and 4B). Associations between TAT and total WBC, neutrophil, monocyte
Table 2. The correlation between regional-specific adipose tissue, WBC, various individual white blood cells and NLR by PCF, TAT quintiles and hepatic steatosis.
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Grade of Hepatic Steatosis
Factors No/Mild (n = 2736) Moderate (n = 277) Severe (n = 183) p (trend)
hs-CRP, mg/L 0.16±0.23 0.19±0.21 0.25±0.26 <0.001
WBC count, (103/mm3) 5.99±1.57 6.28±1.55 6.74±1.70 <0.001
Neutrophil count (103/
mm3)
3.42±1.19 3.57±1.17 3.92±1.27 <0.001
Eosinophil count (103/
mm3)
0.16±0.15 0.16±0.14 0.19±0.15 0.001
Basophil count (103/mm3) 0.02±0.02 0.02±0.02 0.02±0.03 0.69
Monocyte count (103/mm3) 0.40±0.15 0.42±0.15 0.46±0.19 <0.001
Lymphocyte count (103/
mm3)
1.96±0.60 2.04±0.59 2.11±0.63 <0.001
NLR 1.87±0.83 1.84±0.69 1.99±0.81 0.001
WBC: white blood cell; NLR: neutrophil lymphocyte ratio
https://doi.org/10.1371/journal.pone.0207284.t002
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count, and NLR remained statistically significant in fully-adjusted models (Table 4, Model 3,
all p<0.05). Fig 5A-5D demonstrate changes in the c-statistic for models of total WBC count
and NLR as more co-variates were added: (1) age, gender, BMI; (2) model 1 + fasting sugar,
LDL, HDL and eGFR; (3) model 2 + history of hypertension, diabetes, cardiovascular disease
+ lifestyle behaviors (active smoker and regular alcohol use); and (4) model 4 + PCF or TAT.
In the final model 4, addition of TAT—but not PCF—statistically significantly increased the
C-statistic for both total WBC count and NLR (Fig 5A-5D).
Discussion
In this large cohort of subjects who underwent a cardiovascular health survey in Taiwan, we
demonstrate that 3 measures of visceral adiposity—PCF, TAT and hepatic steatosis—are asso-
ciated with circulating WBC counts and the systemic inflammatory marker hs-CRP. More-
over, compared to PCF, TAT appears to be more strongly related to WBC counts and the
NLR, an integrative measure of generalized inflammation, even after accounting for clinical
co-variates. Further, we observed that TAT added independent and incremental value in iden-
tifying abnormally higher total WBC counts and NLR. Our study suggests that regional ectopic
fat deposition of the thoracic aorta (TAT) is associated with systemic inflammation and altered
leukocyte numbers above and beyond clinical characteristics and body anthropometrics.
Peripheral total leukocyte counts (WBC) and its subtypes have previously been associated
with cardiometabolic risk factors including dyslipidemia, obesity, and metabolic syndrome
[20–22]. Higher total WBC counts have been further associated with clinical events such as
incident type 2 diabetes and increased mortality after acute coronary syndromes [23, 24].
Table 3. The regression models for both visceral adipose tissue, hepatic steatosis (moderate-severe degree) with
WBC, it‘s subtypes and NLR.
A
PCF, ml TAT, ml
Factors ß-Coef p value ß-Coef p value
hs-CRP, mg/L 0.09 0.002 0.12 <0.001
WBC count (103/mm3) 0.224 <0.001 0.32 <0.001
Neutrophil count (103/mm3) 0.127 <0.001 0.197 <0.001
Eosinophil count (103/mm3) 0.01 <0.001 0.015 <0.001
Basophil count (103/mm3) 0 0.941 0 0.966
Monocyte count (103/mm3) 0.015 <0.001 0.024 <0.001
Lymphocyte count (103/mm3) 0.059 <0.001 0.078 <0.001
NLR 0.019 0.164 0.042 0.002
B
Hepatic Steatosis (Moderate-Severe Degree)
Factors Coef p value
hs-CRP, mg/L 0.07 0.003
WBC count (103/mm3) 0.35 <0.001
Neutrophil count (103/mm3) 0.23 <0.001
Eosinophil count (103/mm3) 0.014 0.007
Basophil count (103/mm3) ─ ─
Monocyte count (103/mm3) 0.02 <0.001
Lymphocyte count (103/mm3) 0.077 <0.001
NLR 0.03 0.01
WBC: white blood cell; NLR: neutrophil lymphocyte ratio
https://doi.org/10.1371/journal.pone.0207284.t003
Ectopic visceral fat and NLR
PLOS ONE | https://doi.org/10.1371/journal.pone.0207284 November 20, 2018 8 / 16
These and other relevant studies illustrate how atherosclerotic cardiovascular disease is a com-
plex multi-factorial process in which inflammation plays a major role. Abnormal adipose tis-
sue distribution and function are believed to contribute to atherosclerosis, an effect which may
be mediated by inflammation. At the adipose tissue level, inflammation is complex and charac-
terized by dynamic populations of infiltrating neutrophils, macrophages, mast cells, and lym-
phocytes [7, 25]. Among these, adipose tissue macrophages (ATMs), may be the most
important drivers of obesity-related chronic inflammation [26]. In both mouse models and
human subjects, adipocyte hypertrophy induced by excessive caloric intake triggers macro-
phage accumulation in visceral adipose depots where they form so-called “crown-like struc-
tures” (CLSs) around dead adipocytes [27, 28]. These infiltrating macrophages express the
pro-inflammatory M1 phenotype and secrete a variety of inflammatory cytokines such as
tumor necrosis factor-α, interleukin-6 and monocyte chemoattractant protein-1, leading to
up-regulated circulating leukocytes and trigger systemic inflammatory responses [29]. Impor-
tantly, these pro-inflammatory cytokines may act locally on adipocyte function and systemi-
cally on other tissues to promote the pathogenesis of cardiometabolic disease [30]. In our
current work, we demonstrate that both increased PCF and TAT (but not hepatic steatosis)
were independently associated with higher total leukocyte counts after accounting for clinical
co-variates. Of note, only TAT showed independent and incremental value in predicting
abnormally high total leukocyte counts (5900 x 103μL) and higher NLR (>2.51).
Recently, the NLR has been proposed as a simple, clinically available and inexpensive
marker of systemic inflammation, which is helpful for risk stratification of patients with car-
diovascular diseases, diabetes mellitus, metabolic syndrome [11, 31], and for subsequent
adverse cardiovascular events following myocardial infarction [32]. Neutrophils may contrib-
ute to acute myocardial injury by degranulation and secretion of inflammatory cytokines and
proteases, resulting in tissue damage and reperfusion injury [33, 34]. Furthermore, neutrophils
can also invade atherosclerotic plaques and trigger oxidative stress by releasing superoxide
Fig 2. Prevalent hepatic steatosis across PCF, TAT volume quintiles. Subjects with higher quintile of PCF and TAT volume were more likely to have prevalent
Hepatic Steatosis (both p<0.001 for X2 test: 32.2 & 38.7, respectively).
https://doi.org/10.1371/journal.pone.0207284.g002
Ectopic visceral fat and NLR
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radicals, proteolytic enzymes & arachidonic acid derivatives, which all make atherosclerotic
plaques more vulnerable [35]. On the other hand, lymphocytes play an important role in regu-
lating the inflammatory response and are suppressed by corticosteroids in response to the
stress of acute coronary syndrome [36]. In previous studies, however, increased BMI was asso-
ciated with total WBC and individual sub-types but not with NLR [37–39]. A multi-center
study revealed that NLR is positively correlated with hepatic steatosis activity score, pro-
inflammatory cytokines and CRP [40], though in our multi-variate analysis the associations
between hepatic steatosis and all types of leucocytes were attenuated, indicating that hepatic
steatosis might play a lesser role in mediating systemic leucocytes circulation. In aggregate, our
work further expands on these previous observations to show that TAT—a measure of regional
visceral adiposity—, instead of PCF or hepatic steatosis, is tightly associated with NLR beyond
clinical covariates, BMI and lipid profiles. These findings are also consistent with ectopic vis-
ceral fat contributing to elevated cardiovascular risk in “metabolically obese” normal-weight
individuals [41, 42]. While both TAT and PCF remained independently related to total leuco-
cyte counts and NLR, only TAT statistically significantly improved the c-statistic of our fully-
Fig 3. PCF, TAT, NLR, total leukocyte counts across hepatic steatosis category. Higher severity of Hepatic Steatosis [categorized as (1) No/Mild, (2) Moderate,
and (3) Severe] was associated with greater burden of visceral adiposity (A and B) and higher total leukocyte counts (D), but was not associated with NLR (C).
�p<0.05 compared to Non- Hepatic Steatosis group, ¥p<0.05 compared to Moderate Hepatic Steatosis group.
https://doi.org/10.1371/journal.pone.0207284.g003
Ectopic visceral fat and NLR
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adjusted model. This finding may be partly explained by anatomical difference. Elicited
abdominal visceral adipose tissue inflammation close to portal circulation may release fatty
acids and cytokines that directly affect liver (the end-organ), which is considered as the key
factor of hepatic steatosis and insulin resistance [43]. Instead, PCF is anatomically confined
Table 4. Multivariate adjustment models in the association between both visceral adipose tissue, moderate-to-severe hepatic steatosis, WBC, it‘s subtypes and NLR.
Multi-variate Model Multi-variate Model 1 Multi-variate Model 2 Multi-variate Model 3
Factor PCF, ml TAT, ml PCF,ml TAT, ml PCF, ml TAT, ml
ß-Coef p value ß-Coef p value ß-Coef p value ß-Coef p value ß-Coef p value ß-Coef p value
hs-CRP, mg/L 0.06 0.032 0.1 0.001 0.06 0.23 0.06 0.094 0.05 0.52 0.08 0.38
WBC count (103/mm3) 0.243 <0.001 0.339 <0.001 0.107 <0.001 0.208 <0.001 0.135 0.012 0.155 0.011
Neutrophil count (103/mm3) 0.15 <0.001 0.242 <0.001 0.067 0.004 0.169 <0.001 0.065 0.143 0.106 0.04
Eosinophil count (103/mm3) 0.008 0.005 0.01 0.002 0.006 0.099 0.007 0.056 0.004 0.42 0.157 0.073
Basophil count (103/mm3) 0 0.774 0 0.537 0 0.945 0 0.635 0 0.718 0.001 0.27
Monocyte count (103/mm3) 0.015 <0.001 0.021 <0.001 0.007 0.026 0.013 <0.001 0.007 0.243 0.017 0.022
Lymphocyte count (103/mm3) 0.059 <0.001 0.068 <0.001 0.023 0.054 0.023 0.089 0.033 0.12 0.028 0.248
NLR 0.028 0.052 0.072 <0.001 0.02 0.218 0.081 <0.001 0.011 0.52 0.062 0.002
Multi-variate Model (Moderate-to-Severe) Hepatic Steatosis
Factor Multi-variate Model 1 Multi-variate Model 2 Multi-variate Model 3
Coef p value Coef p value Coef p value
hs-CRP, mg/L 0.07 0.004 0.01 0.56 0.004 0.71
WBC count (103/mm3) 0.28 <0.001 0.13 0.01 ─ ─
Neutrophil count (103/mm3) 0.19 <0.001 0.1 0.012 ─ ─
Eosinophil count (103/mm3) ─ ─ ─ ─ ─ ─
Basophil count (103/mm3) ─ ─ ─ ─ ─ ─
Monocyte count (103/mm3) 0.02 0.001 ─ ─ ─ ─
Lymphocyte count (103/mm3) 0.06 0.007 ─ ─ ─ ─
NLR 0.04 0.014 0.03 0.032 ─ ─
Model 1: adjusted for age, gender; Model 2: adjusted for age, gender, BMI; Model 3: adjusted for age, gender, BMI, multi-variate models (MV); BMI: body mass index.
MV: systolic blood pressure, pulse rate, fasting glucose, HDL, LDL, eGFR, medical history of diabetes, hypertension, cardiovascular disease, current smoker, alcohol use.
https://doi.org/10.1371/journal.pone.0207284.t004
Fig 4. Odds of abnormally high WBC (a) and NLR (b) in relation to increasing PCF, TAT, and presence of hepatic steatosis. The crude and adjusted (adj.) odds
ratios (OR) for PCF, TAT and Hepatic Steatosis in identifying abnormally high total leukocyte counts (WBC, cut-off:>6.9 � 103/μL) and NLR (cut-off:>2.51).
https://doi.org/10.1371/journal.pone.0207284.g004
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within the pericardial sac, which was believed to be the source of pro-inflammatory adipokines
near coronary arteries and myocardium. Recent studies have demonstrated close relationships
between PCF and pathogenesis of atherosclerosis or certain degree of myocardial dysfunction
[44, 45] Compared to PCF and hepatic steatosis, TAT may play a more important role in sys-
temic inflammatory process, partly due to the fact that cytokines and pro-inflammatory medi-
ators from TAT can more easily diffuse and distribute through the adventitia layer across the
arterial wall to enter the systemic circulation [12, 46]. This data together with our previous
findings underscores the possibility of using TAT as important metabolic surrogate marker
which may provide additional information in identifying subjects at higher risk of cardiovas-
cular disorders. Further investigation is warranted to explain why different locations of ectopic
visceral fat may be differentially associated with systemic inflammation.
This study has some limitations. Because it is a cross-sectional study, causal inferences can-
not be made and the possibility of residual or unknown confounding cannot be excluded.
Additionally, our subjects may not represent the general population in Taiwan, since they
were participating in a voluntary health survey and were not randomly selected. Our study was
disproportionally male, and so further study in larger female populations is warranted. Finally,
our study represented only a single ethnicity (Taiwanese). In light of racial and ethnic differ-
ences in NLR [47], future studies should examine these relationships in other populations.
Fig 5. The prediction value of abnormally high WBC, NLR by PCF, TAT. The C-statistics of PCF, and TAT in the model prediction for abnormally high
total leukocyte counts (WBC, cut-off:>6.9 � 103/μL)18 and NLR (cut-off:>2.51). Again, TAT demonstrated significant incremental value beyond
conventional cardiovascular risk factors by C-statistics from 0.66 to 0.67 for abnormal WBC, and 0,50 to 0.54 for abnormal NLR (c, d). #p<0.05 in fully
adjusted models.
https://doi.org/10.1371/journal.pone.0207284.g005
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Conclusion
Our study results indicate that greater visceral fat depots appear to be associated with higher
WBC counts and individual cell types independent of body mass index and other traditional
risk factors; however, compared to ectopic fat within the pericardial sac, visceral fat surround-
ing the aorta is more strongly associated with the NLR.
Supporting information
S1 Fig. The relationship between total leukocyte, neutrophil, monocyte, NLR and groups
according to low or high BMI (<24.3,�24.3kg/m2) and low and high PCF/TAT categories
(<71,�71ml for PCF;<6.4,�6.4ml for TAT) based on median values. Total WBC and the
proportion of neutrophil and monocyte tended to increase across BMI and both PCF and
TAT groups (all p for trend: <0.05) For NLR, the association across BMI/TAT categories was
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